DIAMPA LXR 25/5/1000MG TAB

DIAMPA LXR 25/5/1000MG is a triple-action antidiabetic tablet combining Empagliflozin, Linagliptin, and Metformin HCl. This fixed-dose combination is designed to help manage type 2 diabetes by working through multiple mechanisms—improving insulin sensitivity, enhancing glucose excretion, and regulating blood sugar levels. Each tablet delivers a balanced formulation to support better glycemic control. Suitable for patients requiring comprehensive diabetes management. Always use as directed by your healthcare provider.